CULLEN MICHAEL T. (Exec. Chairman, Pres. & CEO) purchased 17.9% of their position (30K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a significant purchase.
P · 1 purchase
Filed: 9/4/2019ACC: 0001437749-19-017893
DirectorOfficer10% Owner· Exec. Chairman, Pres. & CEO
Since Dec 2018
+60K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
17.9%
8/30/2019
168K→198K
Total
Net shares
+30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/30/2019 | P · Purchase | +30K | — | — | 17.9% | 168K | 198K |
| Total | +30K | $0.00 | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
30K shares
Shares
+30K
Strike price
4
Held after
30K
Exercisable
—
8/30/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock30K shares | 8/30/2019 | P · Purchase | +30K | 4 | — | 30K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned194.58K
Total
194.58K indirect194.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 194.58K | Indirect |
| Total | 194.58K | 194.58K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported